Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Large-Scale RNA Interference Screening to Identify Transcriptional Regulators of a Tumor Suppressor Gene.

Forloni M, Ho T, Sun L, Wajapeyee N.

Methods Mol Biol. 2017;1507:261-268.

PMID:
27832546
2.

Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.

Forloni M, Gupta R, Nagarajan A, Sun LS, Dong Y, Pirazzoli V, Toki M, Wurtz A, Melnick MA, Kobayashi S, Homer RJ, Rimm DL, Gettinger SJ, Politi K, Dogra SK, Wajapeyee N.

Cell Rep. 2016 Jul 12;16(2):457-71. doi: 10.1016/j.celrep.2016.05.087. Epub 2016 Jun 23.

3.

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1.

Volodko N, Salla M, Zare A, Abulghasem el-A, Vincent K, Benesch MG, McMullen TP, Bathe OF, Postovit L, Baksh S.

Cancers (Basel). 2016 Jun 10;8(6). pii: E55. doi: 10.3390/cancers8060055.

4.

Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation.

Zhou W, Tian D, He J, Wang Y, Zhang L, Cui L, Jia L, Zhang L, Li L, Shu Y, Yu S, Zhao J, Yuan X, Peng S.

Oncotarget. 2016 Apr 12;7(15):20691-703. doi: 10.18632/oncotarget.7842.

5.

Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer.

Lin RK, Wang YC.

Cell Biosci. 2014 Aug 19;4:46. doi: 10.1186/2045-3701-4-46. eCollection 2014. Review.

6.

The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype.

Fang M, Ou J, Hutchinson L, Green MR.

Mol Cell. 2014 Sep 18;55(6):904-15. doi: 10.1016/j.molcel.2014.08.010. Epub 2014 Sep 11.

7.

AGO2 and SETDB1 cooperate in promoter-targeted transcriptional silencing of the androgen receptor gene.

Cho S, Park JS, Kang YK.

Nucleic Acids Res. 2014 Dec 16;42(22):13545-56. doi: 10.1093/nar/gku788. Epub 2014 Sep 2.

8.

Genetic and pharmacological reactivation of the mammalian inactive X chromosome.

Bhatnagar S, Zhu X, Ou J, Lin L, Chamberlain L, Zhu LJ, Wajapeyee N, Green MR.

Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12591-8. doi: 10.1073/pnas.1413620111. Epub 2014 Aug 18.

9.

Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1.

Lu Y, Wajapeyee N, Turker MS, Glazer PM.

Cell Rep. 2014 Jul 24;8(2):501-13. doi: 10.1016/j.celrep.2014.06.035. Epub 2014 Jul 17.

10.

Is DNA methylation of tumour suppressor genes epigenetic?

Struhl K.

Elife. 2014 Mar 12;3:e02475. doi: 10.7554/eLife.02475.

11.

A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype.

Serra RW, Fang M, Park SM, Hutchinson L, Green MR.

Elife. 2014 Mar 12;3:e02313. doi: 10.7554/eLife.02313.

12.

The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation.

Beckedorff FC, Ayupe AC, Crocci-Souza R, Amaral MS, Nakaya HI, Soltys DT, Menck CF, Reis EM, Verjovski-Almeida S.

PLoS Genet. 2013;9(8):e1003705. doi: 10.1371/journal.pgen.1003705. Epub 2013 Aug 22.

13.

A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.

Nishihara R, Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X, Imamura Y, Nosho K, Shima K, Kawachi I, Qian ZR, Fuchs CS, Chan AT, Giovannucci E, Ogino S.

Am J Epidemiol. 2013 Jul 1;178(1):84-100. doi: 10.1093/aje/kws431. Epub 2013 Jun 20.

14.

Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.

Vasanthakumar A, Lepore JB, Zegarek MH, Kocherginsky M, Singh M, Davis EM, Link PA, Anastasi J, Le Beau MM, Karpf AR, Godley LA.

Blood. 2013 Mar 14;121(11):2059-63. doi: 10.1182/blood-2012-04-421065. Epub 2013 Jan 11.

15.

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E.

Mod Pathol. 2013 Apr;26(4):465-84. doi: 10.1038/modpathol.2012.214. Epub 2013 Jan 11. Review.

16.

High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia.

Hayette S, Thomas X, Jallades L, Chabane K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P, Plesa A, Huet S, Renneville A, Salles G, Nicolini FE, Magaud JP, Michallet M.

PLoS One. 2012;7(12):e51527. doi: 10.1371/journal.pone.0051527. Epub 2012 Dec 10.

17.

The DNMT3B -579 G>T promoter polymorphism and risk of lung cancer.

Liu H, Jiao Y, Guan Y, Lao Y, Zhao C, Fan H.

Exp Ther Med. 2012 Mar;3(3):525-529. Epub 2011 Dec 19.

18.

RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?

Scrace SF, O'Neill E.

Mol Biol Int. 2012;2012:141732. doi: 10.1155/2012/141732. Epub 2012 Apr 11.

19.

Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.

Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, GafĂ  R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA.

Gastroenterology. 2012 Apr;142(4):886-896.e9. doi: 10.1053/j.gastro.2011.12.047. Epub 2012 Jan 10.

20.

Supplemental Content

Support Center